These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 16284881)

  • 1. A new animal model of hyperoxaluria and nephrolithiasis in rats with small bowel resection.
    Worcester EM; Chuang M; Laven B; Orvieto M; Coe FL; Evan AP; Gerber GS
    Urol Res; 2005 Nov; 33(5):380-2. PubMed ID: 16284881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathophysiological correlates of two unique renal tubule lesions in rats with intestinal resection.
    Worcester E; Evan A; Bledsoe S; Lyon M; Chuang M; Orvieto M; Gerber G; Coe F
    Am J Physiol Renal Physiol; 2006 Nov; 291(5):F1061-9. PubMed ID: 17028259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experimental calcium oxalate nephrolithiasis and the formation of human urinary stones.
    Khan SR
    Scanning Microsc; 1995 Mar; 9(1):89-100; discussion 100-1. PubMed ID: 8553028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal histopathology and crystal deposits in patients with small bowel resection and calcium oxalate stone disease.
    Evan AP; Lingeman JE; Worcester EM; Bledsoe SB; Sommer AJ; Williams JC; Krambeck AE; Philips CL; Coe FL
    Kidney Int; 2010 Aug; 78(3):310-7. PubMed ID: 20428098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nephrolithiasis and nephrocalcinosis in rats with small bowel resection.
    O'Connor RC; Worcester EM; Evan AP; Meehan S; Kuznetsov D; Laven B; Sommer AJ; Bledsoe SB; Parks JH; Coe FL; Grynpas M; Gerber GS
    Urol Res; 2005 May; 33(2):105-15. PubMed ID: 15815943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary hyperoxaluria.
    Scheinman JI
    Miner Electrolyte Metab; 1994; 20(6):340-51. PubMed ID: 7783696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enteric hyperoxaluria secondary to small bowel resection: use of computer simulation to characterize urinary risk factors for stone formation and assess potential treatment protocols.
    Rodgers AL; Allie-Hamdulay S; Jackson GE; Sutton RA
    J Endourol; 2014 Aug; 28(8):985-94. PubMed ID: 24773381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Minipump induced hyperoxaluria and crystal deposition in rats: a model for calcium oxalate urolithiasis.
    Marengo SR; Chen D; MacLennan GT; Resnick MI; Jacobs GH
    J Urol; 2004 Mar; 171(3):1304-8. PubMed ID: 14767338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitamin E therapy prevents hyperoxaluria-induced calcium oxalate crystal deposition in the kidney by improving renal tissue antioxidant status.
    Thamilselvan S; Menon M
    BJU Int; 2005 Jul; 96(1):117-26. PubMed ID: 15963133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study of a rat model for calcium oxalate crystal formation without severe renal damage in selected conditions.
    Yamaguchi S; Wiessner JH; Hasegawa AT; Hung LY; Mandel GS; Mandel NS
    Int J Urol; 2005 Mar; 12(3):290-8. PubMed ID: 15828958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Urinary calcium oxalate supersaturation beyond nephrolithiasis. Relationship with tubulointerstitial damage].
    Toblli JE; Angerosa M; Stella I; Ferder L; Inserra F
    Medicina (B Aires); 2003; 63(2):97-104. PubMed ID: 12793076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enteric and mild hyperoxaluria.
    Sutton RA; Walker VR
    Miner Electrolyte Metab; 1994; 20(6):352-60. PubMed ID: 7783697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pyridoxamine lowers kidney crystals in experimental hyperoxaluria: a potential therapy for primary hyperoxaluria.
    Chetyrkin SV; Kim D; Belmont JM; Scheinman JI; Hudson BG; Voziyan PA
    Kidney Int; 2005 Jan; 67(1):53-60. PubMed ID: 15610227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Essential roles of CFEX-mediated Cl(-)-oxalate exchange in proximal tubule NaCl transport and prevention of urolithiasis.
    Aronson PS
    Kidney Int; 2006 Oct; 70(7):1207-13. PubMed ID: 16883319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modeling of hyperoxaluric calcium oxalate nephrolithiasis: experimental induction of hyperoxaluria by hydroxy-L-proline.
    Khan SR; Glenton PA; Byer KJ
    Kidney Int; 2006 Sep; 70(5):914-23. PubMed ID: 16850024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enteric hyperoxaluria, nephrolithiasis, and oxalate nephropathy: potentially serious and unappreciated complications of Roux-en-Y gastric bypass.
    Nelson WK; Houghton SG; Milliner DS; Lieske JC; Sarr MG
    Surg Obes Relat Dis; 2005; 1(5):481-5. PubMed ID: 16925274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipid peroxidation in ethylene glycol induced hyperoxaluria and calcium oxalate nephrolithiasis.
    Thamilselvan S; Hackett RL; Khan SR
    J Urol; 1997 Mar; 157(3):1059-63. PubMed ID: 9072543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathogenesis of oxalate urolithiasis: lessons from experimental studies with rats.
    Khan SR
    Am J Kidney Dis; 1991 Apr; 17(4):398-401. PubMed ID: 2008907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in renal hemodynamics and urodynamics in rats with chronic hyperoxaluria and after acute oxalate infusion: role of free radicals.
    Huang HS; Ma MC; Chen J; Chen CF
    Neurourol Urodyn; 2003; 22(2):176-82. PubMed ID: 12579636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced gastrointestinal passive paracellular permeability contributes to the obesity-associated hyperoxaluria.
    Bashir M; Meddings J; Alshaikh A; Jung D; Le K; Amin R; Ratakonda S; Sharma S; Granja I; Satti M; Asplin J; Hassan H
    Am J Physiol Gastrointest Liver Physiol; 2019 Jan; 316(1):G1-G14. PubMed ID: 30307745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.